Related Experiment Video
Updated: May 9, 2026

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
[A Case of Advanced Gastric Cancer with Early Recurrence after Surgery Treated by Nivolumab]
Kumi Hasegawa1, Masaki Matsumura, Tomohiro Hayakawa
1Dept. of Surgery, Hasuda Hospital.
Abstract:
The patient is a 65-year-old male. He underwent laparoscopic distal gastrectomy for advanced gastric cancer of the lower gastric body. Pathological findings were poorly differentiated adenocarcinoma, Stage ⅢC. The cancerous lesion extended over 15 cm and was extensively positive for margins on the oral side due to marked lymphatic invasion. Two months later, CT showed local peritoneal recurrence, so treatment with nivolumab+SOX was started. The recurrence was resolved, but due to appearance of anorexia 6 months later, the treatment was discontinued. His symptoms worsened further, and hospitalized to receive intravenous infusion. A marked decrease in blood cortisol and ACTH was observed, suggesting hypopituitarism as irAE. After steroid administration, the symptoms resolved quickly. Subsequently, nivolumab+SOX were administered, and a long-term complete response was achieved.
Related Concept Videos
Treatment Resistant Cancers
Tumor Immunotherapy
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
